Business Description
Hualan Biological Bacterin Inc
ISIN : CNE1000058J9
Share Class Description:
SZSE:301207: Class ACompare
Compare
Traded in other countries / regions
301207.China IPO Date
2022-02-18Description
Hualan Biological Bacterin Inc is engaged in human vaccine development, production and sales.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.54 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.4 | |||||
| Interest Coverage | 142.8 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.59 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.8 | |||||
| 3-Year EBITDA Growth Rate | 6.8 | |||||
| 3-Year EPS without NRI Growth Rate | -3.5 | |||||
| 3-Year FCF Growth Rate | 11 | |||||
| 3-Year Book Growth Rate | 57.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.55 | |||||
| 9-Day RSI | 64.66 | |||||
| 14-Day RSI | 61.2 | |||||
| 6-1 Month Momentum % | -14.02 | |||||
| 12-1 Month Momentum % | -6.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.91 | |||||
| Quick Ratio | 2.74 | |||||
| Cash Ratio | 1.31 | |||||
| Days Inventory | 477.96 | |||||
| Days Sales Outstanding | 310.94 | |||||
| Days Payable | 216.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.95 | |||||
| Dividend Payout Ratio | 0.28 | |||||
| Forward Dividend Yield % | 0.95 | |||||
| 5-Year Yield-on-Cost % | 0.99 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 1.62 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.51 | |||||
| Operating Margin % | 43.87 | |||||
| Net Margin % | 32.49 | |||||
| FCF Margin % | 37.89 | |||||
| ROE % | 11.47 | |||||
| ROA % | 8.97 | |||||
| ROIC % | 19.64 | |||||
| ROC (Joel Greenblatt) % | 33.49 | |||||
| ROCE % | 13.33 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.61 | |||||
| PE Ratio without NRI | 24.22 | |||||
| Price-to-Owner-Earnings | 36.56 | |||||
| PS Ratio | 9.58 | |||||
| PB Ratio | 3.15 | |||||
| Price-to-Tangible-Book | 3.18 | |||||
| Price-to-Free-Cash-Flow | 25.26 | |||||
| Price-to-Operating-Cash-Flow | 23.37 | |||||
| EV-to-EBIT | 22.56 | |||||
| EV-to-EBITDA | 22.56 | |||||
| EV-to-Revenue | 8.59 | |||||
| EV-to-FCF | 21.43 | |||||
| Price-to-Graham-Number | 1.85 | |||||
| Price-to-Net-Current-Asset-Value | 5.82 | |||||
| Price-to-Net-Cash | 39.6 | |||||
| Earnings Yield (Greenblatt) % | 4.43 | |||||
| FCF Yield % | 3.96 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hualan Biological Bacterin Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,984.039 | ||
| EPS (TTM) (Â¥) | 1.07 | ||
| Beta | 0 | ||
| Volatility % | 31.9 | ||
| 14-Day RSI | 61.2 | ||
| 14-Day ATR (Â¥) | 0.962487 | ||
| 20-Day SMA (Â¥) | 30.251 | ||
| 12-1 Month Momentum % | -6.91 | ||
| 52-Week Range (Â¥) | 26.79 - 37.34 | ||
| Shares Outstanding (Mil) | 600.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hualan Biological Bacterin Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hualan Biological Bacterin Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hualan Biological Bacterin Inc Frequently Asked Questions
What is Hualan Biological Bacterin Inc(SZSE:301207)'s stock price today?
The current price of SZSE:301207 is ¥31.68. The 52 week high of SZSE:301207 is ¥37.34 and 52 week low is ¥26.79.
When is next earnings date of Hualan Biological Bacterin Inc(SZSE:301207)?
The next earnings date of Hualan Biological Bacterin Inc(SZSE:301207) is .
Does Hualan Biological Bacterin Inc(SZSE:301207) pay dividends? If so, how much?
The Dividend Yield %  of Hualan Biological Bacterin Inc(SZSE:301207) is 0.95% (As of Today), Highest Dividend Payout Ratio of Hualan Biological Bacterin Inc(SZSE:301207) was 0.28. The lowest was 0.17. And the median was 0.17. The  Forward Dividend Yield % of Hualan Biological Bacterin Inc(SZSE:301207) is 0.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers